ARK Genomic Revolution ETF

Premium/discount is how far the market price trades above (+) or below (−) the fund's net asset value (reported in USD).

3-year risk statistics are not currently available for this fund.

Risk statistics are 3-year, month-end-based.

Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.

Fees & expenses

Category

Equity – SectorHealth Care

Asset class

Equity

Strategy

Active

Themes

Genomics

Sector

Health Care

Issuer

ARK Investment Management LLC

Branding

ARK

Similar ETFs

Funds sharing the same category or exposures.

• GNOMUS

  Global X Genomics & Biotechnology ETF

  Same category · Same sector · genomics

  $105.69M0.500%+54.60%
• HELXUS

  Franklin Genomic Advancements ETF

  Same category · Same sector · genomics

  $33.20M0.500%+22.01%
• XLVUS

  State Street® Health Care Select Sector SPDR® ETF

  Same category · Same sector

  $43.92B0.080%+11.63%
• IBBUS

  iShares Biotechnology ETF

  Same category · Same sector

  $10.64B0.440%+24.41%
• VGTUS

  Vanguard Information Technology Index Fund

  Same group

  $170.65B0.090%+34.36%
• XLKUS

  State Street® Technology Select Sector SPDR® ETF

  Same group

  $127.79B0.080%+36.81%

Frequently asked questions

What is ARKG's expense ratio?

ARK Genomic Revolution ETF charges a net expense ratio of 0.750%.

How large is ARK Genomic Revolution ETF?

ARKG holds $2.17B in assets under management.

What index does ARKG track?

ARK Genomic Revolution ETF tracks NASDAQ Health Care as its primary benchmark.

When did ARKG launch?

ARK Genomic Revolution ETF launched on October 31, 2014.

What currency does ARKG trade in?

ARKG trades in USD on Cboe BZX U.S. Equities Exchange.

Fund information